Echinacea appears in the INCI lists of many hair care and scalp treatment products, often paired with promises of “strengthening” or “vitality.” Its chemistry is more specific: its main actives are caffeoylquinic acids and alkylamides that act on precise molecular targets within the extracellular matrix of the perifollicular dermis. Hairswiss analyzes.
Phytochemical composition of Echinacea purpurea
Echinacea purpurea (Asteraceae family) contains four families of bioactive compounds relevant to hair cosmetology:
- Caffeoylquinic acids — primarily chicoric acid (MW 474 Da, ~0.6–2.1% in aerial parts) and caftaric acid (MW 312 Da). These are the primary active markers of standardized extracts.
- Alkylamides (MW 200–350 Da) — echinacea-specific lipophilic compounds, including the isobutylamide of undecylenic acid. Their lipophilicity (logP ~4–6) gives them good percutaneous penetration.
- Immunomodulating polysaccharides — arabinogalactans and heteroglycans (MW 10,000–400,000 Da), mainly active orally. In topical cosmetology, their high MW limits penetration.
- Glycoproteins — activators of cutaneous macrophages, of interest in the context of inflamed scalp.
Key mechanism of action: hyaluronidase inhibition
The best documented mechanism of echinacea in the hair context is hyaluronidase inhibition. This enzyme degrades hyaluronic acid (HA) in the extracellular matrix (ECM) of the perifollicular dermis. The dermal papilla — containing the signaling cells that govern the hair cycle — is embedded in an HA-rich ECM. Its degradation reduces the integrity of this microenvironment and can impair papillary signaling.
Chicoric acid and alkylamides inhibit hyaluronidase in vitro at concentrations in the range of IC₅₀ = 0.1–0.5 mg/mL. By protecting matrix HA from enzymatic degradation, they contribute to preserving the integrity of the dermal papilla microenvironment and, indirectly, anagen phase activity.
Anti-inflammatory effects on the scalp
Echinacea alkylamides are partial ligands of cannabinoid CB2 receptors (expressed on keratinocytes and cutaneous immune cells). Their activation reduces the release of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), which can limit chronic scalp inflammation — a contributing factor in stress-induced telogen effluvium and seborrheic dermatitis.
Limits: distinction between oral and topical use
Most clinical data on echinacea concerns oral immunomodulatory use. In topical hair application, penetration is the limiting factor: only alkylamides (lipophilic, MW <350 Da) effectively penetrate the epidermis. Caffeoylquinic acids (hydrophilic, MW >300 Da) remain primarily at the surface. The efficacy of a topical echinacea extract therefore depends directly on its alkylamide content and the formulation technology used (microencapsulation, lipid carriers).
Professional products: Echinacea in formulation on cliCHair
Among the products available on cliCHair.ch integrating Echinacea purpurea as a functional ingredient, the INEJ Smooth line by Code Zero Hair includes the extract in its shampoo, conditioner and mask. The formulation pairs Echinacea Purpurea extract with hydrolyzed soy and rice proteins and panthenol, targeting scalp inflammation and structural fiber reinforcement simultaneously. Professionals looking to integrate anti-inflammatory scalp care into their protocols will find the INEJ Smooth Shampoo on cliCHair.ch.
What Hairswiss concludes
Echinacea is an interesting phytochemical active in hair cosmetology, but its topical efficacy depends on the extract quality and alkylamide content — the only fractions lipophilic enough to penetrate the scalp. Hyaluronidase inhibition is its best documented mechanism in the hair context: it preserves the ECM of the dermal papilla and indirectly the anagen cycle microenvironment. An extract titrated in alkylamides is preferable to a non-standardized extract to guarantee measurable activity.